Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Net Equity Issued and Repurchased (2011 - 2018)

Soligenix's (SNGX) quarterly Net Equity Issued and Repurchased came in at $8.6 million in Q3 2018, up 1904.93% YoY from $428870.0 in Q3 2017, and up 46128.74% on a QoQ basis from $18600.0 in Q2 2018.

Soligenix (SNGX) Net Equity Issued and Repurchased (2011 - 2018) Analysis & Trends

Soligenix (SNGX) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $8.6 million in Q3 2018.

  • Quarterly Net Equity Issued and Repurchased rose 1904.93% year-over-year to $8.6 million in Q3 2018, while the trailing twelve-month figure through Sep 2023 was $8.6 million (changed N/A YoY) and the FY2016 annual result came in at $3.0 million, down 21.86% from the prior year.
  • Net Equity Issued and Repurchased grew to $8.6 million in Q3 2018, from $18600.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.6 million in Q3 2018 to a low of $18600.0 in Q2 2018.
  • A 5-year average of $1.3 million and a median of $337697.5 in 2015 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased plunged 78.95% — and 2018, when it surged 1904.93%.
  • Tracing SNGX's Net Equity Issued and Repurchased over 5 years: stood at $156000.0 in 2014, then soared by 1325.74% to $2.2 million in 2015, then retreated by 8.4% to $2.0 million in 2016, then sank by 78.95% to $428870.0 in 2017, then surged by 1904.93% to $8.6 million in 2018.
  • The last three Net Equity Issued and Repurchased figures came in at $8.6 million (Q3 2018), $18600.0 (Q2 2018), and $19800.0 (Q1 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Soligenix 6.45 Mn 6.45 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2018 8.60 Mn
Sep 30, 2018 8.60 Mn
Jun 30, 2018 18,600.00
Jun 30, 2018 18,600.00
Mar 31, 2018 19,800.00
Mar 31, 2018 19,800.00
Sep 30, 2017 428,870.00
Sep 30, 2017 428,870.00
Sep 30, 2016 2.04 Mn
Sep 30, 2016 2.04 Mn
Dec 31, 2015 2.22 Mn
Dec 31, 2015 2.22 Mn
Sep 30, 2015 500,000.00
Sep 30, 2015 500,000.00
Jun 30, 2015 868,500.00
Jun 30, 2015 868,500.00
Mar 31, 2015 246,525.00
Mar 31, 2015 246,525.00
Sep 30, 2014 156,000.00
Sep 30, 2014 156,000.00